Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
12.68
+0.08 (0.63%)
Nov 17, 2025, 11:38 AM EST - Market open
RGC Employees
Regencell Bioscience Holdings had 10 employees as of June 30, 2025. The number of employees decreased by 2 or -16.67% compared to the previous year.
Employees
10
Change (1Y)
-2
Growth (1Y)
-16.67%
Revenue / Employee
n/a
Profits / Employee
-$358,421
Market Cap
6.27B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 10 | -2 | -16.67% |
| Jun 30, 2024 | 12 | 0 | - |
| Jun 30, 2023 | 12 | -1 | -7.69% |
| Jun 30, 2022 | 13 | -1 | -7.14% |
| Jun 30, 2021 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RGC News
- 5 months ago - This Chinese Herb Stock Is Now Bigger Than Super Micro And Reddit - Benzinga
- 5 months ago - Top 3 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
- 5 months ago - This stock with no revenue surges 64,000% in a year: find out why - Invezz
- 3 years ago - Regencell Bioscience's Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial - Business Wire
- 3 years ago - Slow And Steady Wins The Race With Regencell Bioscience - Seeking Alpha
- 3 years ago - Sector Rotation And 9 Stocks To Watch During A Recession - Benzinga
- 3 years ago - Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period - Business Wire
- 3 years ago - Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO - Business Wire